Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging
Authors not listed
Hopital Lariboisière · 2005
Abstract
Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Anonymous. (2005). Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging. <em>Hopital Lariboisière</em>. https://clinicaltrials.gov/study/NCT00299624
Vancouver
Anonymous. Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging. Hopital Lariboisière. 2005.
BibTeX
@misc{anon2005Identi,
title = {Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging},
author = {Anonymous},
journal = {Hopital Lariboisière},
year = {2005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Elsevier eBooks 2025
Citation only
Epigenetics of life cycle: from prenatal events to aging
Springer eBooks 2005
Citation only
Cardiac Fibrosis and Aging
Elsevier eBooks 2022
Citation only
Aging
GeroScience 2025
Preprint · OA
Glycemic status-dependent proteomic signatures of biological aging for health risk prediction
Washington University School of Medicine 2025
Open access · US-GOV
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
Research Square 2026
Preprint · CC-BY